Status:
UNKNOWN
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
Lead Sponsor:
Hadassah Medical Organization
Conditions:
ATOPIC DERMATITIS
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Atopic dermatitis (AD) is a chronic inflammatory skin disease, affecting 20% of all babies and children around the world. Diagnosis of atopic dermatitis is clinical and depends on the existence of at ...
Detailed Description
Atopic dermatitis (AD) is a chronic inflammatory skin disease, affecting 20% of all babies and children around the world. In 90% of the cases the disease first appears before the age of five and in 65...
Eligibility Criteria
Inclusion
- patient with atopic dermatitis,
- Hebrew-speaking men and women,
- over 18 years old.
Exclusion
- hospital where the diagnosis of atopic dermatitis is not sure,
- patients under the age of 18, pregnant women, no - helpless, soldiers and prisoners,
- patients with atopic dermatitis treated with systemic preparations such as cyclosporine, steroids, antibiotics, methotrexate, biological preparations.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01174511
Start Date
July 1 2011
End Date
November 1 2012
Last Update
July 6 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.